{"entity":{"type":"insider","cik":"0001354718","url":"/insider/0001354718","json_url":"/insider/0001354718.json","name":"Halak Brian K","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":187,"n_filings":87,"first":"2008-03-26","last":"2019-08-08","span_basis":"filed_date"},"name_variants":[{"name":"Halak Brian K","source":"filing","n_filings":87,"first_seen":"2008-03-26","last_seen":"2019-08-08"}],"transactions":[{"id":8472765,"accession":"0000904454-19-000600","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-19-000600","line_url":"/filing/0000904454-19-000600#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"OBALON THERAPEUTICS INC","issuer_ticker":"OBLN","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; TREU JESSE I; BLAIR JAMES C; VITULLO NICOLE; Halak Brian K; DOMAIN PARTERS VII L P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":1000000.0,"total_display":"1,000,000.00","shares_owned_after":813433.0,"shares_owned_after_display":"813,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-06","filed_date":"2019-08-08","scope":"insider"},{"id":6286763,"accession":"0000904454-18-000702","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000904454-18-000702","line_url":"/filing/0000904454-18-000702#line-8","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102067.0,"shares_display":"102,067","price_per_share":13.18,"price_display":"13.18","price_state":"stated","total_value":1345243.06,"total_display":"1,345,243.06","shares_owned_after":2588024.0,"shares_owned_after_display":"2,588,024","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-06","filed_date":"2018-11-06","scope":"insider"},{"id":6286760,"accession":"0000904454-18-000702","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000904454-18-000702","line_url":"/filing/0000904454-18-000702#line-7","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1489.0,"shares_display":"1,489","price_per_share":14.16,"price_display":"14.16","price_state":"stated","total_value":21084.24,"total_display":"21,084.24","shares_owned_after":2586535.0,"shares_owned_after_display":"2,586,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-06","filed_date":"2018-11-06","scope":"insider"},{"id":6286757,"accession":"0000904454-18-000702","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000904454-18-000702","line_url":"/filing/0000904454-18-000702#line-6","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":761.0,"shares_display":"761","price_per_share":13.18,"price_display":"13.18","price_state":"stated","total_value":10029.98,"total_display":"10,029.98","shares_owned_after":19161.0,"shares_owned_after_display":"19,161","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-06","filed_date":"2018-11-06","scope":"insider"},{"id":6286754,"accession":"0000904454-18-000702","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000904454-18-000702","line_url":"/filing/0000904454-18-000702#line-5","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11.0,"shares_display":"11","price_per_share":14.16,"price_display":"14.16","price_state":"stated","total_value":155.76,"total_display":"155.76","shares_owned_after":19150.0,"shares_owned_after_display":"19,150","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-06","filed_date":"2018-11-06","scope":"insider"},{"id":6286753,"accession":"0000904454-18-000702","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000904454-18-000702","line_url":"/filing/0000904454-18-000702#line-4","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39606.0,"shares_display":"39,606","price_per_share":12.98,"price_display":"12.98","price_state":"stated","total_value":514085.88,"total_display":"514,085.88","shares_owned_after":2690091.0,"shares_owned_after_display":"2,690,091","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-05","filed_date":"2018-11-06","scope":"insider"},{"id":6286750,"accession":"0000904454-18-000702","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-18-000702","line_url":"/filing/0000904454-18-000702#line-3","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":295.0,"shares_display":"295","price_per_share":12.98,"price_display":"12.98","price_state":"stated","total_value":3829.1,"total_display":"3,829.10","shares_owned_after":19922.0,"shares_owned_after_display":"19,922","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-05","filed_date":"2018-11-06","scope":"insider"},{"id":6286747,"accession":"0000904454-18-000702","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-18-000702","line_url":"/filing/0000904454-18-000702#line-2","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":189359.0,"shares_display":"189,359","price_per_share":13.47,"price_display":"13.47","price_state":"stated","total_value":2550665.73,"total_display":"2,550,665.73","shares_owned_after":2729697.0,"shares_owned_after_display":"2,729,697","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-02","filed_date":"2018-11-06","scope":"insider"},{"id":6286744,"accession":"0000904454-18-000702","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-18-000702","line_url":"/filing/0000904454-18-000702#line-1","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1412.0,"shares_display":"1,412","price_per_share":13.47,"price_display":"13.47","price_state":"stated","total_value":19019.64,"total_display":"19,019.64","shares_owned_after":20217.0,"shares_owned_after_display":"20,217","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-02","filed_date":"2018-11-06","scope":"insider"},{"id":9206249,"accession":"0000904454-18-000697","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000904454-18-000697","line_url":"/filing/0000904454-18-000697#line-7","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":188867.0,"shares_display":"188,867","price_per_share":13.37,"price_display":"13.37","price_state":"stated","total_value":2525151.79,"total_display":"2,525,151.79","shares_owned_after":2919056.0,"shares_owned_after_display":"2,919,056","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-01","filed_date":"2018-11-05","scope":"insider"},{"id":9206248,"accession":"0000904454-18-000697","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000904454-18-000697","line_url":"/filing/0000904454-18-000697#line-8","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1408.0,"shares_display":"1,408","price_per_share":13.37,"price_display":"13.37","price_state":"stated","total_value":18824.96,"total_display":"18,824.96","shares_owned_after":21629.0,"shares_owned_after_display":"21,629","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-01","filed_date":"2018-11-05","scope":"insider"},{"id":6898724,"accession":"0000904454-18-000691","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000904454-18-000691","line_url":"/filing/0000904454-18-000691#line-8","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":188167.0,"shares_display":"188,167","price_per_share":13.37,"price_display":"13.37","price_state":"stated","total_value":2515792.79,"total_display":"2,515,792.79","shares_owned_after":2919056.0,"shares_owned_after_display":"2,919,056","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-01","filed_date":"2018-11-01","scope":"insider"},{"id":6898720,"accession":"0000904454-18-000691","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000904454-18-000691","line_url":"/filing/0000904454-18-000691#line-7","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1408.0,"shares_display":"1,408","price_per_share":13.37,"price_display":"13.37","price_state":"stated","total_value":18824.96,"total_display":"18,824.96","shares_owned_after":21629.0,"shares_owned_after_display":"21,629","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-01","filed_date":"2018-11-01","scope":"insider"},{"id":9206250,"accession":"0000904454-18-000697","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000904454-18-000697","line_url":"/filing/0000904454-18-000697#line-6","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":959.0,"shares_display":"959","price_per_share":13.6,"price_display":"13.60","price_state":"stated","total_value":13042.4,"total_display":"13,042.40","shares_owned_after":23037.0,"shares_owned_after_display":"23,037","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-31","filed_date":"2018-11-05","scope":"insider"},{"id":9206243,"accession":"0000904454-18-000697","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000904454-18-000697","line_url":"/filing/0000904454-18-000697#line-5","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":128670.0,"shares_display":"128,670","price_per_share":13.6,"price_display":"13.60","price_state":"stated","total_value":1749912.0,"total_display":"1,749,912.00","shares_owned_after":3107923.0,"shares_owned_after_display":"3,107,923","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-31","filed_date":"2018-11-05","scope":"insider"},{"id":6898717,"accession":"0000904454-18-000691","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000904454-18-000691","line_url":"/filing/0000904454-18-000691#line-6","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":128670.0,"shares_display":"128,670","price_per_share":13.6,"price_display":"13.60","price_state":"stated","total_value":1749912.0,"total_display":"1,749,912.00","shares_owned_after":3107923.0,"shares_owned_after_display":"3,107,923","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-31","filed_date":"2018-11-01","scope":"insider"},{"id":6898713,"accession":"0000904454-18-000691","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000904454-18-000691","line_url":"/filing/0000904454-18-000691#line-5","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":959.0,"shares_display":"959","price_per_share":13.6,"price_display":"13.60","price_state":"stated","total_value":13042.4,"total_display":"13,042.40","shares_owned_after":23037.0,"shares_owned_after_display":"23,037","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-31","filed_date":"2018-11-01","scope":"insider"},{"id":9206247,"accession":"0000904454-18-000697","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-18-000697","line_url":"/filing/0000904454-18-000697#line-1","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":152364.0,"shares_display":"152,364","price_per_share":13.68,"price_display":"13.68","price_state":"stated","total_value":2084339.52,"total_display":"2,084,339.52","shares_owned_after":3327511.0,"shares_owned_after_display":"3,327,511","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-30","filed_date":"2018-11-05","scope":"insider"},{"id":9206246,"accession":"0000904454-18-000697","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-18-000697","line_url":"/filing/0000904454-18-000697#line-2","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1136.0,"shares_display":"1,136","price_per_share":13.68,"price_display":"13.68","price_state":"stated","total_value":15540.48,"total_display":"15,540.48","shares_owned_after":24674.0,"shares_owned_after_display":"24,674","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-30","filed_date":"2018-11-05","scope":"insider"},{"id":9206245,"accession":"0000904454-18-000697","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-18-000697","line_url":"/filing/0000904454-18-000697#line-3","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90918.0,"shares_display":"90,918","price_per_share":14.31,"price_display":"14.31","price_state":"stated","total_value":1301036.58,"total_display":"1,301,036.58","shares_owned_after":3236593.0,"shares_owned_after_display":"3,236,593","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-30","filed_date":"2018-11-05","scope":"insider"},{"id":9206244,"accession":"0000904454-18-000697","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000904454-18-000697","line_url":"/filing/0000904454-18-000697#line-4","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":678.0,"shares_display":"678","price_per_share":14.31,"price_display":"14.31","price_state":"stated","total_value":9702.18,"total_display":"9,702.18","shares_owned_after":23996.0,"shares_owned_after_display":"23,996","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-30","filed_date":"2018-11-05","scope":"insider"},{"id":6898709,"accession":"0000904454-18-000691","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000904454-18-000691","line_url":"/filing/0000904454-18-000691#line-4","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":152364.0,"shares_display":"152,364","price_per_share":13.68,"price_display":"13.68","price_state":"stated","total_value":2084339.52,"total_display":"2,084,339.52","shares_owned_after":3327511.0,"shares_owned_after_display":"3,327,511","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-30","filed_date":"2018-11-01","scope":"insider"},{"id":6898705,"accession":"0000904454-18-000691","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-18-000691","line_url":"/filing/0000904454-18-000691#line-3","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90918.0,"shares_display":"90,918","price_per_share":14.31,"price_display":"14.31","price_state":"stated","total_value":1301036.58,"total_display":"1,301,036.58","shares_owned_after":3236593.0,"shares_owned_after_display":"3,236,593","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-30","filed_date":"2018-11-01","scope":"insider"},{"id":6898701,"accession":"0000904454-18-000691","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-18-000691","line_url":"/filing/0000904454-18-000691#line-2","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1136.0,"shares_display":"1,136","price_per_share":13.68,"price_display":"13.68","price_state":"stated","total_value":15540.48,"total_display":"15,540.48","shares_owned_after":24674.0,"shares_owned_after_display":"24,674","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-30","filed_date":"2018-11-01","scope":"insider"},{"id":6898697,"accession":"0000904454-18-000691","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-18-000691","line_url":"/filing/0000904454-18-000691#line-1","is_derivative":false,"issuer_cik":"0001354718","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001354718","owner_cik":"0001354718","owner_name":"Halak Brian K","owner_url":"/insider/0001354718","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":678.0,"shares_display":"678","price_per_share":14.31,"price_display":"14.31","price_state":"stated","total_value":9702.18,"total_display":"9,702.18","shares_owned_after":23996.0,"shares_owned_after_display":"23,996","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-30","filed_date":"2018-11-01","scope":"insider"},{"id":6436667,"accession":"0000904454-18-000526","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-18-000526","line_url":"/filing/0000904454-18-000526#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"OBALON THERAPEUTICS INC","issuer_ticker":"OBLN","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Halak Brian K; DOVEY BRIAN H; TREU JESSE I; DOMAIN PARTERS VII L P; BLAIR JAMES C; VITULLO NICOLE","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1648359.0,"shares_display":"1,648,359","price_per_share":1.82,"price_display":"1.82","price_state":"stated","total_value":3000013.38,"total_display":"3,000,013.38","shares_owned_after":5634329.0,"shares_owned_after_display":"5,634,329","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-23","filed_date":"2018-08-27","scope":"insider"},{"id":6254408,"accession":"0000904454-18-000522","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-18-000522","line_url":"/filing/0000904454-18-000522#line-3","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"BioNano Genomics, Inc","issuer_ticker":"BNGO","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; VITULLO NICOLE; Halak Brian K; BLAIR JAMES C; Domain Partners VIII, L.P.; DOVEY BRIAN H","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":6.125,"price_display":"6.12","price_state":"stated","total_value":91875.0,"total_display":"91,875.00","shares_owned_after":943878.0,"shares_owned_after_display":"943,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-23","filed_date":"2018-08-27","scope":"insider"},{"id":3069945,"accession":"0000904454-16-001237","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001237","line_url":"/filing/0000904454-16-001237#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; DP VII ASSOCIATES LP; Halak Brian K; TREU JESSE I; VITULLO NICOLE; BLAIR JAMES C","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5880.0,"shares_display":"5,880","price_per_share":4.7,"price_display":"4.70","price_state":"stated","total_value":27636.0,"total_display":"27,636.00","shares_owned_after":10328.0,"shares_owned_after_display":"10,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-26","filed_date":"2016-05-27","scope":"insider"},{"id":2080165,"accession":"0000904454-16-001235","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001235","line_url":"/filing/0000904454-16-001235#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; Halak Brian K; DOMAIN PARTERS VII L P; BLAIR JAMES C; VITULLO NICOLE; TREU JESSE I","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":344120.0,"shares_display":"344,120","price_per_share":4.7,"price_display":"4.70","price_state":"stated","total_value":1617364.0,"total_display":"1,617,364.00","shares_owned_after":606283.0,"shares_owned_after_display":"606,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-26","filed_date":"2016-05-27","scope":"insider"},{"id":2863423,"accession":"0000904454-16-001187","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001187","line_url":"/filing/0000904454-16-001187#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; DOMAIN PARTERS VII L P; DOVEY BRIAN H; TREU JESSE I; BLAIR JAMES C; Halak Brian K","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3603.0,"shares_display":"3,603","price_per_share":5.02,"price_display":"5.02","price_state":"stated","total_value":18087.06,"total_display":"18,087.06","shares_owned_after":950403.0,"shares_owned_after_display":"950,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-27","filed_date":"2016-04-27","scope":"insider"},{"id":2311064,"accession":"0000904454-16-001190","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001190","line_url":"/filing/0000904454-16-001190#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; TREU JESSE I; VITULLO NICOLE; DP VII ASSOCIATES LP; DOVEY BRIAN H; Halak Brian K","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61.0,"shares_display":"61","price_per_share":5.02,"price_display":"5.02","price_state":"stated","total_value":306.22,"total_display":"306.22","shares_owned_after":16208.0,"shares_owned_after_display":"16,208","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-27","filed_date":"2016-04-27","scope":"insider"},{"id":2863417,"accession":"0000904454-16-001187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001187","line_url":"/filing/0000904454-16-001187#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; DOMAIN PARTERS VII L P; DOVEY BRIAN H; TREU JESSE I; BLAIR JAMES C; Halak Brian K","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1492.0,"shares_display":"1,492","price_per_share":5.2,"price_display":"5.20","price_state":"stated","total_value":7758.4,"total_display":"7,758.40","shares_owned_after":954006.0,"shares_owned_after_display":"954,006","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-25","filed_date":"2016-04-27","scope":"insider"},{"id":2311058,"accession":"0000904454-16-001190","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001190","line_url":"/filing/0000904454-16-001190#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; TREU JESSE I; VITULLO NICOLE; DP VII ASSOCIATES LP; DOVEY BRIAN H; Halak Brian K","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21.0,"shares_display":"21","price_per_share":5.2,"price_display":"5.20","price_state":"stated","total_value":109.2,"total_display":"109.20","shares_owned_after":16269.0,"shares_owned_after_display":"16,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-25","filed_date":"2016-04-27","scope":"insider"},{"id":2361943,"accession":"0000904454-16-001172","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001172","line_url":"/filing/0000904454-16-001172#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DP VII ASSOCIATES LP; DOVEY BRIAN H; TREU JESSE I; Halak Brian K; VITULLO NICOLE","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76.0,"shares_display":"76","price_per_share":5.29,"price_display":"5.29","price_state":"stated","total_value":402.04,"total_display":"402.04","shares_owned_after":16290.0,"shares_owned_after_display":"16,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-20","filed_date":"2016-04-21","scope":"insider"},{"id":2311053,"accession":"0000904454-16-001170","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001170","line_url":"/filing/0000904454-16-001170#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; VITULLO NICOLE; DOMAIN PARTERS VII L P; BLAIR JAMES C; Halak Brian K; TREU JESSE I","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4424.0,"shares_display":"4,424","price_per_share":5.29,"price_display":"5.29","price_state":"stated","total_value":23402.96,"total_display":"23,402.96","shares_owned_after":955498.0,"shares_owned_after_display":"955,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-20","filed_date":"2016-04-21","scope":"insider"},{"id":2361937,"accession":"0000904454-16-001172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001172","line_url":"/filing/0000904454-16-001172#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DP VII ASSOCIATES LP; DOVEY BRIAN H; TREU JESSE I; Halak Brian K; VITULLO NICOLE","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":632.0,"shares_display":"632","price_per_share":5.36,"price_display":"5.36","price_state":"stated","total_value":3387.52,"total_display":"3,387.52","shares_owned_after":16366.0,"shares_owned_after_display":"16,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-19","filed_date":"2016-04-21","scope":"insider"},{"id":2311047,"accession":"0000904454-16-001170","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001170","line_url":"/filing/0000904454-16-001170#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; VITULLO NICOLE; DOMAIN PARTERS VII L P; BLAIR JAMES C; Halak Brian K; TREU JESSE I","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37054.0,"shares_display":"37,054","price_per_share":5.36,"price_display":"5.36","price_state":"stated","total_value":198609.44,"total_display":"198,609.44","shares_owned_after":959922.0,"shares_owned_after_display":"959,922","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-19","filed_date":"2016-04-21","scope":"insider"},{"id":2311044,"accession":"0000904454-16-001166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001166","line_url":"/filing/0000904454-16-001166#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Halak Brian K; DOVEY BRIAN H; TREU JESSE I; BLAIR JAMES C; VITULLO NICOLE; DP VII ASSOCIATES LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75.0,"shares_display":"75","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":391.5,"total_display":"391.50","shares_owned_after":16998.0,"shares_owned_after_display":"16,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-11","filed_date":"2016-04-13","scope":"insider"},{"id":2268807,"accession":"0000904454-16-001164","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001164","line_url":"/filing/0000904454-16-001164#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Halak Brian K; TREU JESSE I; DOVEY BRIAN H; BLAIR JAMES C; VITULLO NICOLE; DOMAIN PARTERS VII L P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4348.0,"shares_display":"4,348","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":22696.56,"total_display":"22,696.56","shares_owned_after":996976.0,"shares_owned_after_display":"996,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-11","filed_date":"2016-04-13","scope":"insider"},{"id":2903334,"accession":"0000904454-16-001154","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-16-001154","line_url":"/filing/0000904454-16-001154#line-3","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOMAIN PARTERS VII L P; BLAIR JAMES C; Halak Brian K; TREU JESSE I; DOVEY BRIAN H; VITULLO NICOLE","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14554.0,"shares_display":"14,554","price_per_share":5.35,"price_display":"5.35","price_state":"stated","total_value":77863.9,"total_display":"77,863.90","shares_owned_after":1001324.0,"shares_owned_after_display":"1,001,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-08","filed_date":"2016-04-08","scope":"insider"},{"id":2773146,"accession":"0000904454-16-001156","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-16-001156","line_url":"/filing/0000904454-16-001156#line-3","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; TREU JESSE I; DOVEY BRIAN H; DP VII ASSOCIATES LP; BLAIR JAMES C; Halak Brian K","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":251.0,"shares_display":"251","price_per_share":5.35,"price_display":"5.35","price_state":"stated","total_value":1342.85,"total_display":"1,342.85","shares_owned_after":17073.0,"shares_owned_after_display":"17,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-08","filed_date":"2016-04-08","scope":"insider"},{"id":2903328,"accession":"0000904454-16-001154","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001154","line_url":"/filing/0000904454-16-001154#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOMAIN PARTERS VII L P; BLAIR JAMES C; Halak Brian K; TREU JESSE I; DOVEY BRIAN H; VITULLO NICOLE","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27781.0,"shares_display":"27,781","price_per_share":5.26,"price_display":"5.26","price_state":"stated","total_value":146128.06,"total_display":"146,128.06","shares_owned_after":1015878.0,"shares_owned_after_display":"1,015,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-07","filed_date":"2016-04-08","scope":"insider"},{"id":2773139,"accession":"0000904454-16-001156","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001156","line_url":"/filing/0000904454-16-001156#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; TREU JESSE I; DOVEY BRIAN H; DP VII ASSOCIATES LP; BLAIR JAMES C; Halak Brian K","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":475.0,"shares_display":"475","price_per_share":5.26,"price_display":"5.26","price_state":"stated","total_value":2498.5,"total_display":"2,498.50","shares_owned_after":17324.0,"shares_owned_after_display":"17,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-07","filed_date":"2016-04-08","scope":"insider"},{"id":2903320,"accession":"0000904454-16-001154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001154","line_url":"/filing/0000904454-16-001154#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOMAIN PARTERS VII L P; BLAIR JAMES C; Halak Brian K; TREU JESSE I; DOVEY BRIAN H; VITULLO NICOLE","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8669.0,"shares_display":"8,669","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":45252.18,"total_display":"45,252.18","shares_owned_after":1043659.0,"shares_owned_after_display":"1,043,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-06","filed_date":"2016-04-08","scope":"insider"},{"id":2773125,"accession":"0000904454-16-001156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001156","line_url":"/filing/0000904454-16-001156#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; TREU JESSE I; DOVEY BRIAN H; DP VII ASSOCIATES LP; BLAIR JAMES C; Halak Brian K","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":148.0,"shares_display":"148","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":772.56,"total_display":"772.56","shares_owned_after":17799.0,"shares_owned_after_display":"17,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-06","filed_date":"2016-04-08","scope":"insider"},{"id":8778943,"accession":"0000904454-15-000538","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-15-000538","line_url":"/filing/0000904454-15-000538#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; DP VII ASSOCIATES LP; VITULLO NICOLE; BLAIR JAMES C; Halak Brian K; TREU JESSE I; SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":202.0,"shares_display":"202","price_per_share":7.02,"price_display":"7.02","price_state":"stated","total_value":1418.04,"total_display":"1,418.04","shares_owned_after":17947.0,"shares_owned_after_display":"17,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-20","scope":"insider"},{"id":8653651,"accession":"0000904454-15-000536","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-15-000536","line_url":"/filing/0000904454-15-000536#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; DOMAIN PARTERS VII L P; Halak Brian K; TREU JESSE I; VITULLO NICOLE","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11836.0,"shares_display":"11,836","price_per_share":7.02,"price_display":"7.02","price_state":"stated","total_value":83088.72,"total_display":"83,088.72","shares_owned_after":1052328.0,"shares_owned_after_display":"1,052,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-20","scope":"insider"},{"id":8125638,"accession":"0000904454-15-000262","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-15-000262","line_url":"/filing/0000904454-15-000262#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Regado Biosciences Inc","issuer_ticker":"TBRA","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; TREU JESSE I; Halak Brian K; DOMAIN PARTERS VII L P; BLAIR JAMES C; SCHOEMAKER KATHLEEN K; VITULLO NICOLE","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":277777.0,"shares_display":"277,777","price_per_share":10.62,"price_display":"10.62","price_state":"stated","total_value":2949991.74,"total_display":"2,949,991.74","shares_owned_after":3553322.0,"shares_owned_after_display":"3,553,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-04","filed_date":"2015-05-06","scope":"insider"},{"id":8125635,"accession":"0000904454-15-000244","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-15-000244","line_url":"/filing/0000904454-15-000244#line-3","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DP VII ASSOCIATES LP; Halak Brian K; TREU JESSE I; BLAIR JAMES C; VITULLO NICOLE; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":554.0,"shares_display":"554","price_per_share":7.07,"price_display":"7.07","price_state":"stated","total_value":3916.78,"total_display":"3,916.78","shares_owned_after":18149.0,"shares_owned_after_display":"18,149","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-16","filed_date":"2015-04-16","scope":"insider"},{"id":8048899,"accession":"0000904454-15-000246","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-15-000246","line_url":"/filing/0000904454-15-000246#line-3","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; Halak Brian K; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; DOMAIN PARTERS VII L P; BLAIR JAMES C; TREU JESSE I","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32411.0,"shares_display":"32,411","price_per_share":7.07,"price_display":"7.07","price_state":"stated","total_value":229145.77,"total_display":"229,145.77","shares_owned_after":1064164.0,"shares_owned_after_display":"1,064,164","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-16","filed_date":"2015-04-16","scope":"insider"}],"next_cursor":"2015-04-16|8048899","ledger_fault":false,"count":{"value":78,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":53,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":78},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001427570","name":"OBALON THERAPEUTICS INC","url":"/issuer/0001427570","role":"Ten percent owner","n_filings":2,"first_seen":"2018-08-27","last_seen":"2019-08-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001399529","name":"Dicerna Pharmaceuticals Inc","url":"/issuer/0001399529","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2018-11-01","last_seen":"2018-11-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001411690","name":"BioNano Genomics, Inc","url":"/issuer/0001411690","role":"Ten percent owner","n_filings":1,"first_seen":"2018-08-27","last_seen":"2018-08-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001403708","name":"Evoke Pharma Inc","url":"/issuer/0001403708","role":"Ten percent owner","n_filings":14,"first_seen":"2015-04-16","last_seen":"2016-05-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001311596","name":"Regado Biosciences Inc","url":"/issuer/0001311596","role":"Ten percent owner","n_filings":1,"first_seen":"2015-05-06","last_seen":"2015-05-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001618835","name":"Neothetics, Inc.","url":"/issuer/0001618835","role":"Ten percent owner","n_filings":2,"first_seen":"2014-11-26","last_seen":"2014-12-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001434868","name":"Esperion Therapeutics, Inc.","url":"/issuer/0001434868","role":"Ten percent owner","n_filings":2,"first_seen":"2013-07-02","last_seen":"2014-10-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001604464","name":"Atara Biotherapeutics, Inc.","url":"/issuer/0001604464","role":"Ten percent owner","n_filings":2,"first_seen":"2014-10-21","last_seen":"2014-10-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001274644","name":"Ocera Therapeutics, Inc.","url":"/issuer/0001274644","role":"Ten percent owner","n_filings":2,"first_seen":"2013-07-16","last_seen":"2013-07-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001466301","name":"Clovis Oncology, Inc.","url":"/issuer/0001466301","role":"Ten percent owner","n_filings":5,"first_seen":"2011-11-21","last_seen":"2013-06-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001333248","name":"CADENCE PHARMACEUTICALS INC","url":"/issuer/0001333248","role":"Ten percent owner","n_filings":37,"first_seen":"2009-02-20","last_seen":"2013-04-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001544116","name":"Durata Therapeutics, Inc.","url":"/issuer/0001544116","role":"Ten percent owner","n_filings":1,"first_seen":"2012-07-24","last_seen":"2012-07-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001382911","name":"Orexigen Therapeutics, Inc.","url":"/issuer/0001382911","role":"Ten percent owner","n_filings":12,"first_seen":"2008-12-10","last_seen":"2011-12-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001375151","name":"ZOGENIX, INC.","url":"/issuer/0001375151","role":"Ten percent owner","n_filings":2,"first_seen":"2010-12-01","last_seen":"2011-09-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001354217","name":"Volcano CORP","url":"/issuer/0001354217","role":"Ten percent owner","n_filings":1,"first_seen":"2008-03-26","last_seen":"2008-03-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001354718","retrieved_at":"2026-08-21T11:21:46+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}